Cargando…
Is the Evaluation of Quality of Life in NSCLC Trials Important? Are the Results to be Trusted?
The majority of patients with non-small cell lung cancer present at the time of diagnosis with stage IV metastatic disease and they experience 2 or more disease-related symptoms. These symptoms may have a negative impact on their health-related quality of life (HR QOL). Data has shown many of these...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080131/ https://www.ncbi.nlm.nih.gov/pubmed/25072024 http://dx.doi.org/10.3389/fonc.2014.00173 |